Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
NIHR Biomedical Research Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. emb34@cam.ac.uk
Donor dendritic cells are potent but short-lived stimulators of early transplant rejection, and recipient antigen presenting cells presenting donor major histocompatibility complex peptides sustain immunoreactivity and contribute to chronic rejection. We briefly consider how CD4 T cells that recognize allopeptide can provide help for effector and regulatory responses and highlight the implications for promoting graft survival.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on